Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18421383rdf:typepubmed:Citationlld:pubmed
pubmed-article:18421383lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:18421383lifeskim:mentionsumls-concept:C2699488lld:lifeskim
pubmed-article:18421383lifeskim:mentionsumls-concept:C0599473lld:lifeskim
pubmed-article:18421383pubmed:issue9lld:pubmed
pubmed-article:18421383pubmed:dateCreated2008-4-18lld:pubmed
pubmed-article:18421383pubmed:abstractTextThe straightforward synthesis of both enantiomers of cis-5'-hydroxythalidomide, a major metabolite of thalidomide, has been accomplished by enzymatic kinetic resolution of a racemic substrate catalyzed by Pseudomonas stutzeri lipase TL. cis-5'-Hydroxythalidomide shows resistance to racemization (and epimerization) at physiological pH. A tube formation assay to assess the ability to inhibit angiogenesis revealed that cis-5'-hydroxythalidomides are inactive.lld:pubmed
pubmed-article:18421383pubmed:languageenglld:pubmed
pubmed-article:18421383pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18421383pubmed:citationSubsetIMlld:pubmed
pubmed-article:18421383pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18421383pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18421383pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18421383pubmed:statusMEDLINElld:pubmed
pubmed-article:18421383pubmed:monthMaylld:pubmed
pubmed-article:18421383pubmed:issn1477-0520lld:pubmed
pubmed-article:18421383pubmed:authorpubmed-author:YamamotoTakes...lld:pubmed
pubmed-article:18421383pubmed:authorpubmed-author:SummersLinda...lld:pubmed
pubmed-article:18421383pubmed:authorpubmed-author:NakamuraShuic...lld:pubmed
pubmed-article:18421383pubmed:authorpubmed-author:ToruTakeshiTlld:pubmed
pubmed-article:18421383pubmed:authorpubmed-author:ShibataNorioNlld:pubmed
pubmed-article:18421383pubmed:authorpubmed-author:TakashimaMasa...lld:pubmed
pubmed-article:18421383pubmed:authorpubmed-author:MatsunagaNozo...lld:pubmed
pubmed-article:18421383pubmed:issnTypePrintlld:pubmed
pubmed-article:18421383pubmed:day7lld:pubmed
pubmed-article:18421383pubmed:volume6lld:pubmed
pubmed-article:18421383pubmed:ownerNLMlld:pubmed
pubmed-article:18421383pubmed:authorsCompleteYlld:pubmed
pubmed-article:18421383pubmed:pagination1540-3lld:pubmed
pubmed-article:18421383pubmed:meshHeadingpubmed-meshheading:18421383...lld:pubmed
pubmed-article:18421383pubmed:meshHeadingpubmed-meshheading:18421383...lld:pubmed
pubmed-article:18421383pubmed:meshHeadingpubmed-meshheading:18421383...lld:pubmed
pubmed-article:18421383pubmed:meshHeadingpubmed-meshheading:18421383...lld:pubmed
pubmed-article:18421383pubmed:meshHeadingpubmed-meshheading:18421383...lld:pubmed
pubmed-article:18421383pubmed:meshHeadingpubmed-meshheading:18421383...lld:pubmed
pubmed-article:18421383pubmed:meshHeadingpubmed-meshheading:18421383...lld:pubmed
pubmed-article:18421383pubmed:meshHeadingpubmed-meshheading:18421383...lld:pubmed
pubmed-article:18421383pubmed:year2008lld:pubmed
pubmed-article:18421383pubmed:articleTitleEnzymatic resolution and evaluation of enantiomers of cis-5'-hydroxythalidomide.lld:pubmed
pubmed-article:18421383pubmed:affiliationDepartment of Frontier Materials, Graduate School of Engineering, Nagoya Institute of Technology, Gokiso, Showa-ku, Nagoya 466-8555, Japan.lld:pubmed
pubmed-article:18421383pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18421383pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18421383lld:pubmed